SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001171843-20-001712
Filing Date
2020-03-13
Accepted
2020-03-13 16:05:12
Documents
6
Period of Report
2020-01-24
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A f8ka_031320.htm 8-K/A 16106
2 EXHIBIT 23.1 exh_231.htm EX-23.1 2013
3 EXHIBIT 99.1 exh_991.htm EX-99.1 170171
4 EXHIBIT 99.2 exh_992.htm EX-99.2 151875
5 GRAPHIC wa_hdr.jpg GRAPHIC 6865
6 GRAPHIC wa_sig.jpg GRAPHIC 3010
  Complete submission text file 0001171843-20-001712.txt   355256
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-14027 | Film No.: 20712640
SIC: 3841 Surgical & Medical Instruments & Apparatus